We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$802M
AUM Growth
+$26.7M
Cap. Flow
+$2.39M
Cap. Flow %
0.3%
Top 10 Hldgs %
28.66%
Holding
337
New
15
Increased
53
Reduced
138
Closed
9

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$9.04M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$3.38M
3
AMD icon
Advanced Micro Devices
AMD
+$2M
4
TECD
Tech Data Corp
TECD
+$1.52M
5
QCOM icon
Qualcomm
QCOM
+$618K

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$8.72M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$1.76M
3
TWLO icon
Twilio
TWLO
+$731K
4
UAA icon
Under Armour
UAA
+$709K
5
LUV icon
Southwest Airlines
LUV
+$684K

Sector Composition

Rank Sector Weight
1 Healthcare 22.98%
2 Industrials 15.02%
3 Technology 10.52%
4 Financials 9.61%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
26
Invesco QQQ Trust
QQQ
$471B
$7.32M 0.91%
50,337
-1,802
-3% -$258K
GE icon
27
GE Aerospace
GE
$354B
$7.24M 0.9%
62,495
-3,547
-5% -$429K
GILD icon
28
Gilead Sciences
GILD
$165B
$6.59M 0.82%
81,292
-1,800
-2% -$138K
MMP
29
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.37M 0.79%
89,686
-606
-0.7% -$41.8K
NSC icon
30
Norfolk Southern
NSC
$75.2B
$6.34M 0.79%
47,948
+5
+0% +$608
WMT icon
31
Walmart Inc
WMT
$878B
$6.15M 0.77%
236,229
-5,250
-2% -$138K
TMO icon
32
Thermo Fisher Scientific
TMO
$196B
$6.03M 0.75%
31,848
-375
-1% -$67.9K
IBM icon
33
IBM
IBM
$198B
$5.7M 0.71%
41,086
+660
+2% +$91.9K
RTX icon
34
RTX Corp
RTX
$262B
$5.5M 0.69%
75,344
+1,381
+2% +$102K
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$122B
$5.42M 0.68%
35,670
-1,400
-4% -$211K
PFE icon
36
Pfizer
PFE
$142B
$5.35M 0.67%
157,898
-12,425
-7% -$399K
XOM icon
37
ExxonMobil
XOM
$629B
$5.31M 0.66%
64,828
-1,320
-2% -$105K
MRK icon
38
Merck
MRK
$307B
$5.22M 0.65%
85,437
– –
NVDA icon
39
NVIDIA
NVDA
$5.02T
$5.04M 0.63%
1,126,800
+2,000
+0.2% +$8.31K
EPD icon
40
Enterprise Products Partners
EPD
$83.9B
$4.94M 0.62%
189,393
-2,324
-1% -$61.4K
EL icon
41
Estee Lauder
EL
$30.3B
$4.88M 0.61%
45,234
– –
IBB icon
42
iShares Biotechnology ETF
IBB
$9.37B
$4.86M 0.61%
43,731
-504
-1% -$53.9K
HYG icon
43
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.4B
$4.73M 0.59%
53,256
-586
-1% -$51.7K
CVX icon
44
Chevron
CVX
$378B
$4.7M 0.59%
40,030
-268
-0.7% -$29.3K
KSU
45
DELISTED
Kansas City Southern
KSU
$4.6M 0.57%
42,330
– –
IYG icon
46
iShares US Financial Services ETF
IYG
$2.13B
$4.59M 0.57%
114,816
+1,284
+1% +$49.2K
FDX icon
47
FedEx
FDX
$73.1B
$4.57M 0.57%
20,239
– –
CSCO icon
48
Cisco
CSCO
$442B
$4.42M 0.55%
131,271
-2,452
-2% -$78.1K
EOG icon
49
EOG Resources
EOG
$75.1B
$4.26M 0.53%
44,020
-150
-0.3% -$13.5K
AMZN icon
50
Amazon
AMZN
$2.66T
$4.23M 0.53%
88,060
+2,100
+2% +$103K
1
2
3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Gerald L. Ray & Associates held 337 positions worth $802M, up 3.4% from $775M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q3 2017 filing shows 15 new, 53 increased, 138 reduced and 9 closed positions. Its largest new stake was Clovis Oncology, Inc.: 42,630 shares worth $3.51M. The largest sale was Du Pont De Nemours E I, an estimated $8.72M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

  • Gerald L. Ray & Associates's largest Q3 2017 buy was Clovis Oncology, Inc.: 42,630 shares worth $3.51M.
  • Gerald L. Ray & Associates added most to DuPont de Nemours in Q3 2017, an estimated $9.04M increase.
  • Gerald L. Ray & Associates's biggest Q3 2017 reduction was Under Armour, cutting an estimated $709K.
  • Gerald L. Ray & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $8.72M.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $802M portfolio in Q3 2017.
  • Gerald L. Ray & Associates opened 15 new positions and closed 9 in Q3 2017.
  • Gerald L. Ray & Associates's portfolio value rose 3.4% quarter-over-quarter to $802M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.